Company news

Kwang Dong Pharmaceutical Co., Ltd. news

Latest news releases, newest first.

Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

September 15, 2025